Benign essential blepharospasm: Clinical Trials

9 trials for Benign essential blepharospasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting. 3 Phase 3, 3 Phase 4, 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 43Completed 2, Recruiting 1
Not applicable2Completed 2
Phase 22Completed 1, Recruiting 1

Follow Benign essential blepharospasm: new trials by email Literature Review of Benign essential blepharospasm trials Research Report on Benign essential blepharospasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DaxibotulinumtoxinA for Blepharospasm
Botulinum Neurotoxin Type A - Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid
Phase 2RecruitingUniversity of Pennsylvania202026-09-242026-09-29
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm
DaxibotulinumtoxinA - Benign Essential Blepharospasm, Hemifacial Spasm
Phase 4RecruitingMontefiore Medical Center402025-02-112026-04-23
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
Cannabidiol Oral Solution [Epidiolex] - Blepharospasm, Blepharospasm, Benign Essential
Phase 2 / Phase 3CompletedSilkiss Eye Surgery122020-05-202021-11-02
The Role of the Upper Colliculus in the Idiopathic Blepharospasm
fMRI - Blepharospasm, Benign Essential
Not applicableCompletedUniversity Hospital, Grenoble132019-11-202022-09-16
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm
Neuronox, Botox - Essential Blepharospasm
Phase 3CompletedMedy-Tox1402016-05-252017-07-13
The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
Botulinum toxin type A - Essential Blepharospasm
Phase 4CompletedHugel2492015-04-302018-08-22
rTMS and Botulinum Toxin in Benign Essential Blepharospasm
Magstim RapidStim2, Sham Magstim RapidStim2 - Benign Essential Blepharospasm
Not applicableCompletedUniversity of Florida122015-02-012023-09-15
Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Botulinum Toxin Type A - Essential Blepharospasm
Phase 4CompletedMedy-Tox1102010-08-012012-04-25
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Hugeltox, Botulinum Toxin Type A(Botox®) - Essential Blepharospasm
Phase 3CompletedHugel1722008-04-012013-02-15

Narrower conditions

Blepharospasm (2)  ·  Dystonia (1)  ·  Hemifacial Spasm (1)  ·  Parkinsonian Disorders (1)

Broader conditions

Eye Diseases (2)  ·  Eyelid Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dyskinesias (1)  ·  Mouth Diseases (1)  ·  Movement Disorders (1)  ·  Neuromuscular Manifestations (1)  ·  Spasm (1)  ·  Stomatognathic Diseases (1)

Interventions

Botulinum Toxins, Type A (6)  ·  Cannabidiol (1)  ·  Injections (1)

Sponsors

Hugel (2)  ·  Medy-Tox (2)  ·  Montefiore Medical Center (1)  ·  Silkiss Eye Surgery (1)  ·  University Hospital, Grenoble (1)  ·  University of Florida (1)  ·  University of Pennsylvania (1)

Countries

United States (4)  ·  South Korea (3)  ·  France (1)

Top investigators

Anne Barmettler, MD (1)  ·  Aparna Wagle-Shukla, MD (1)  ·  Jaechan Kim, M.D., Ph.D. (1)  ·  Sara Meoni, MD, PhD (1)  ·  Yoon-Duck Kim, M.D., Ph.D. (1)

Results publications

PMID 37606606, PMID 39426359

NIH funding

2023 (1)